Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible reset ...

Forward Air ended the quarter with $393 million in liquidity, up from $382 million at the end of Q4 2024. The company generated free cash flow of $16.4 million in Q1.

Fidelity Overseas Fund's Retail Class shares gained 6.49%, trailing the 6.94% advance of the benchmark MSCI EAFE Index (Net ...